Sign in
CompletedPhase 1

A study to compare how different substances (caffeine, warfarin, omeprazole, metoprolol, and midazolam) are handled by the body of healthy people and people with liver cirrhosis

Key facts

Who runs it
Boehringer Ingelheim International GmbH
Where
Germany1 site in 1 countryChoose a country to see its sites
Status
Completed
Phase
Phase 1
People taking part
30 people enrolled
Started
25 Apr 2023
Ended
31 Dec 2024
Type of study
Interventional
Record updated
26 July 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

Where is this trial?

It has sites in one country. Choose a country to see its sites.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
26 July 2024